These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 8037414)

  • 41. [Aseptic meningitis following treatment with immunoglobulins: physiopathological and prognostic value of screening].
    Oddou S; Molinier S; Coso D; Boulet JM; Gastaut JA; Bouabdallah R
    Presse Med; 1995 May; 24(19):916. PubMed ID: 7638138
    [No Abstract]   [Full Text] [Related]  

  • 42. Side-effects of intravenous immune globulins.
    Duhem C; Dicato MA; Ries F
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):79-83. PubMed ID: 8033440
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acute encephalopathy associated with intravenous immunoglobulin therapy.
    Wada A; Yoshida R; Oda K; Fukuba E; Uchida N; Kitagaki H
    AJNR Am J Neuroradiol; 2005 Oct; 26(9):2311-5. PubMed ID: 16219838
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aseptic meningitis caused by intravenous immunoglobulin.
    Fernández Carril JM; Trejo JM; Sedano MJ; Goñi M
    Neurologia; 1995 Oct; 10(8):351-2. PubMed ID: 8554788
    [No Abstract]   [Full Text] [Related]  

  • 45. Intractable headache: aseptic meningitis and sphenoidal sinusitis.
    Silberstein SD
    Cephalalgia; 1994 Oct; 14(5):376-8. PubMed ID: 7828199
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Case of IVIG-Induced Aseptic Chemical Meningitis.
    Patel A; Potu KC; Sturm T
    S D Med; 2017 Mar; 70(3):119-121. PubMed ID: 28813773
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Intravenous immune globulin and acute aseptic meningitis.
    Casteels-Van Daele M; Wijndaele L; Hanninck K; Gillis P
    N Engl J Med; 1990 Aug; 323(9):614-5. PubMed ID: 2381452
    [No Abstract]   [Full Text] [Related]  

  • 48. Neurological complications of intravenous immunoglobulin (IVIg) therapy: an illustrative case of acute encephalopathy following IVIg therapy and a review of the literature.
    Mathy I; Gille M; Van Raemdonck F; Delbecq J; Depré A
    Acta Neurol Belg; 1998 Dec; 98(4):347-51. PubMed ID: 9922823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intravenous immunoglobulin-associated thrombosis: is it such a rare event? Report of a pediatric case and of the Quebec Hemovigilance System.
    Benadiba J; Robitaille N; Lambert G; Itaj NK; Pastore Y
    Transfusion; 2015 Mar; 55(3):571-5. PubMed ID: 25355613
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Adverse effects of intravenous human polyvalent immunoglobulins].
    Chapuis C; Guy N; Besson G
    Rev Neurol (Paris); 2008 Sep; 164 Spec No 3():F203-10. PubMed ID: 18992580
    [No Abstract]   [Full Text] [Related]  

  • 51. Increased levels of Monocyte Chemoattractant Protein-1 in cerebrospinal fluid with gamma globulin induced meningitis.
    Asano T; Koizumi S; Mishina-Ikegami K; Hatori T; Miyasho T; Fujino O
    Acta Paediatr; 2010 Feb; 99(2):164-5. PubMed ID: 19832741
    [No Abstract]   [Full Text] [Related]  

  • 52. Aseptic meningitis associated with high dose intravenous immunoglobulin therapy.
    Casteels-Van Daele M; Wijndaele L; Brock P; Kruger M; Gillis P
    J Neurol Neurosurg Psychiatry; 1992 Oct; 55(10):980-1. PubMed ID: 1431974
    [No Abstract]   [Full Text] [Related]  

  • 53. [Aseptic meningitis during treatment with high-dose intravenous immunoglobulins].
    Fain O; Eclache V; Sitbon M; Thomas M
    Presse Med; 1996 Apr; 25(13):643. PubMed ID: 8668698
    [No Abstract]   [Full Text] [Related]  

  • 54. A new subset of common variable immune deficiency characterized by reduced C1 esterase inhibitor levels.
    Melamed IR; Heffron M; McGee S; Ulltate Sanz L; Testori A
    Ann Allergy Asthma Immunol; 2015 Jul; 115(1):83-4. PubMed ID: 26123426
    [No Abstract]   [Full Text] [Related]  

  • 55. Pituitary apoplexy presenting as chemical meningitis.
    Brouns R; Crols R; Engelborghs S; De Deyn PP
    Lancet; 2004 Aug 7-13; 364(9433):502. PubMed ID: 15302191
    [No Abstract]   [Full Text] [Related]  

  • 56. Adverse effects of IgG therapy.
    Berger M
    J Allergy Clin Immunol Pract; 2013; 1(6):558-66. PubMed ID: 24565701
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Immunoglobulin-induced aseptic meningitis: a case report.
    Graça L; Alves J; Nuak J; Sarmento A
    BMC Neurol; 2018 Jul; 18(1):97. PubMed ID: 30016937
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Aseptic meningitis after intradural anesthesia].
    Papaceit Vidal J; Linares Gil MJ; del Moral MV
    Rev Esp Anestesiol Reanim; 1990; 37(3):153-5. PubMed ID: 2389075
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The nurse's role in administration of intravenous immunoglobulin therapy.
    Kirmse J
    Home Healthc Nurse; 2009 Feb; 27(2):104-11; quiz 112-3. PubMed ID: 19212223
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug-induced aseptic meningitis: diagnosis and management.
    Jolles S; Sewell WA; Leighton C
    Drug Saf; 2000 Mar; 22(3):215-26. PubMed ID: 10738845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.